PEG化タンパク質の世界市場予測：PEG化キット、PEG化試薬...市場調査レポートについてご紹介

1 Introduction (Page No. – 10)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 14)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 21)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 28)
4.1 Global PEGylated Proteins Market Overiew
4.2 Market: By End-User & Region
4.3 Market: Geographic Snapshot
4.4 Life Cycle Analysis, By Region (2016)

5 Industry Insights (Page No. – 32)
5.1 Introduction
5.2 Market Indicators
5.2.1 Increasing R&D Spending in Pharmaceutical and Biotechnology Sector
5.3 Strategic Benchmarking
5.3.1 Agreement & Collaboration
5.4 Porter’s Five Forces Analysis
5.4.1 Threat From New Entrants
5.4.2 Threat From Substitutes
5.4.3 Bargaining Power of Suppliers
5.4.4 Bargaining Power of Buyers
5.4.5 Intensity of Competitive Rivalry
5.5 Regulatory Scenario
5.6 Pipeline Analysis

6 Market Overview (Page No. – 41)
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Increase in R&D Spending
6.2.1.2 Growth in Biologics Sector to Propel the PEGylated Proteins Market
6.2.1.3 Increase in Adoption of Protein-Based Drugs Over Non-Protein-Based Drugs
6.2.1.4 Increasing Protein’s Stability and Circulating Half-Life
6.2.1.5 High Prevalence Rate of Lifestyle Diseases
6.2.2 Restraints
6.2.2.1 Drug Failure and Recalls Hinders Market Growth
6.2.3 Opportunities
6.2.3.1 Rising Opportunities in Emerging Markets
6.2.3.2 Top-Selling Biologics Drugs Going Off–Patent in the Near Future
6.2.4 Challenge
6.2.4.1 Increasing Market Consolidation Increases Entry Barriers and Restraints Market Growth

7 PEGylated Proteins Market, By Product (Page No. – 48)
7.1 Introduction
7.2 Consumbales
7.2.1 Pegylation Kits
7.2.2 Pegylation Reagents
7.2.2.1 Monofunctional Linear Pegs
7.2.2.2 Bifunctional Pegs
7.2.2.3 Multi-Arm Pegs
7.2.2.4 Branched Pegs
7.2.2.5 Other Pegylation Reagents
7.3 Services
7.3.1 Development of PEGylated Biosimilars
7.3.2 Process Development of Peg-Drug Conjugate Manufacturing
7.3.3 Pilot Production of Peg Drug Conjugate
7.3.4 Development of Analytical Methods
7.3.5 Pegylation Feasibility Studies

8 PEGylated Proteins Market, By Protein Type (Page No. – 66)
8.1 Key Findings
8.2 Introduction
8.3 Colongy Stimulating Factors
8.4 Interferons
8.5 Erythropoietin (EPO)
8.6 Recombinant Factor Viii
8.7 Monoclonal Antibodies
8.8 Other Protein Type

9 PEGylated Proteins Market, By Application (Page No. – 77)
9.1 Key Findings
9.2 Introduction
9.3 Cancer Treatment
9.4 HEPAtitis
9.5 Chronic Kidney Disease
9.6 Hemophilia
9.7 Multiple Sclerosis
9.8 Gastrointestinal Disorder
9.9 Other Application

10 End-User Market, By End-User (Page No. – 89)
10.1 Key Findings
10.2 Introduction
10.3 Pharmaceutical & Biotechnology Companies
10.4 Contract Research Organization
10.5 Academic Research Institutes

11 PEGylated Proteins Market, By Region (Page No. – 96)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.4 Asia
11.5 Rest of the World

12 Competitive Landscape (Page No. – 135)
12.1 Introduction
12.2 Strategic Analysis
12.3 Market Share Analysis
12.4 Competitive Situation and Trends
12.4.1 Agreements & Collaboration
12.4.2 New Product Launches and Product Showcase
12.4.3 Acquisitions
12.4.4 Product Upgradation

13 Company Profiles (Page No. – 142)
13.1 Introduction
13.2 Merck Millipore
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.2.4.1 Financial Analysis
13.2.4.2 Strategic Analysis
13.3 Thermo Fisher Scientific Inc.
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.3.4.1 Financial Analysis
13.3.4.2 Strategic Analysis
13.4 NOF American Corporation (A Subsidiary of NOF Corporation)
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.4.4.1 Financial Analysis
13.4.4.2 Strategic Analysis
13.5 Jenkem Technology
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Recent Developments
13.5.3.1 Strategic Analysis
13.6 Creative Pegworks
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.7 Celares GmbH
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.8 Quanta Biodesign, Ltd
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Recent Developments
13.9 Biomatrik, Inc.
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Recent Developments
13.10 Iris Biotech GmbH
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Laysan Bio, Inc.
13.11.1 Business Overview
13.11.2 Products Offered
13.11.3 Recent Developments

14 Appendix (Page No. – 168)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports